| Id |
Subject |
Object |
Predicate |
Lexical cue |
| TextSentencer_T1 |
0-113 |
Sentence |
denotes |
Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China. |
| TextSentencer_T2 |
114-125 |
Sentence |
denotes |
Importance: |
| TextSentencer_T3 |
126-394 |
Sentence |
denotes |
While the outbreak of coronavirus disease 2019 (COVID-19) has resulted in more than 100 000 infected individuals in China and worldwide, there are few reports on the association of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with ocular abnormalities. |
| TextSentencer_T4 |
395-563 |
Sentence |
denotes |
Understanding ocular manifestations of patients with COVID-19 by ophthalmologists and others may facilitate the diagnosis and prevention of transmission of the disease. |
| TextSentencer_T5 |
564-574 |
Sentence |
denotes |
Objective: |
| TextSentencer_T6 |
575-678 |
Sentence |
denotes |
To investigate ocular manifestations and viral prevalence in the conjunctiva of patients with COVID-19. |
| TextSentencer_T7 |
679-713 |
Sentence |
denotes |
Design, Setting, and Participants: |
| TextSentencer_T8 |
714-898 |
Sentence |
denotes |
In this case series, patients with COVID-19 treated from February 9 to 15, 2020, at a hospital center in Hubei province, China, were retrospectively reviewed for ocular manifestations. |
| TextSentencer_T9 |
899-1138 |
Sentence |
denotes |
During the period of treatment, the ocular signs and symptoms as well as results of blood tests and reverse transcriptase-polymerase chain reaction (RT-PCR) from nasopharyngeal and conjunctival swabs for SARS-CoV-2 were noted and analyzed. |
| TextSentencer_T10 |
1139-1166 |
Sentence |
denotes |
Main Outcomes and Measures: |
| TextSentencer_T11 |
1167-1253 |
Sentence |
denotes |
Ocular signs and symptoms as well as results of blood tests and RT-PCR for SARS-CoV-2. |
| TextSentencer_T12 |
1254-1262 |
Sentence |
denotes |
Results: |
| TextSentencer_T13 |
1263-1393 |
Sentence |
denotes |
Of the 38 included patients with clinically confirmed COVID-19, 25 (65.8%) were male, and the mean (SD) age was 65.8 (16.6) years. |
| TextSentencer_T14 |
1394-1629 |
Sentence |
denotes |
Among them, 28 patients (73.7%) had positive findings for COVID-19 on RT-PCR from nasopharyngeal swabs, and of these, 2 patients (5.2%) yielded positive findings for SARS-CoV-2 in their conjunctival as well as nasopharyngeal specimens. |
| TextSentencer_T15 |
1630-1822 |
Sentence |
denotes |
A total of 12 of 38 patients (31.6%; 95% CI, 17.5-48.7) had ocular manifestations consistent with conjunctivitis, including conjunctival hyperemia, chemosis, epiphora, or increased secretions. |
| TextSentencer_T16 |
1823-2068 |
Sentence |
denotes |
By univariate analysis, patients with ocular symptoms were more likely to have higher white blood cell and neutrophil counts and higher levels of procalcitonin, C-reactive protein, and lactate dehydrogenase than patients without ocular symptoms. |
| TextSentencer_T17 |
2069-2225 |
Sentence |
denotes |
In addition, 11 of 12 patients with ocular abnormalities (91.7%; 95% CI, 61.5-99.8) had positive results for SARS-CoV-2 on RT-PCR from nasopharyngeal swabs. |
| TextSentencer_T18 |
2226-2340 |
Sentence |
denotes |
Of these, 2 (16.7%) had positive results for SARS-CoV-2 on RT-PCR from both conjunctival and nasopharyngeal swabs. |
| TextSentencer_T19 |
2341-2367 |
Sentence |
denotes |
Conclusions and Relevance: |
| TextSentencer_T20 |
2368-2509 |
Sentence |
denotes |
In this study, one-third of patients with COVID-19 had ocular abnormalities, which frequently occurred in patients with more severe COVID-19. |
| TextSentencer_T21 |
2510-2609 |
Sentence |
denotes |
Although there is a low prevalence of SARS-CoV-2 in tears, it is possible to transmit via the eyes. |
